clofibrate and gastrins

clofibrate has been researched along with gastrins in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gavey, CJ; Nwokolo, CU; Pounder, RE; Smith, JT1
Barbolt, TA; Bonner, FW; Eason, CT; Henry, DC; Sauerschell, RJ; Spencer, AJ1
Bonner, FW; Eason, CT; Henry, DC; Howells, DD; Pattison, A; Spencer, AJ1
Baldwin, GS; Ford, J; Lachal, S; Shulkes, A1

Other Studies

4 other study(ies) available for clofibrate and gastrins

ArticleYear
Clofibrate raises human 24 h intragastric acidity but does not affect plasma gastrin concentration.
    British journal of clinical pharmacology, 1990, Volume: 29, Issue:4

    Topics: Adult; Clofibrate; Female; Gastric Acid; Gastrins; Humans

1990
Gastric morphological changes including carcinoid tumors in animals treated with a potent hypolipidemic agent, ciprofibrate.
    Toxicologic pathology, 1989, Volume: 17, Issue:1 Pt 1

    Topics: Animals; Callitrichinae; Carcinoid Tumor; Clofibrate; Clofibric Acid; Fibric Acids; Gastric Mucosa; Gastrins; Hypolipidemic Agents; Male; Mice; Microscopy, Electron; Rats; Rats, Inbred F344; Stomach Neoplasms

1989
Species variation in gastric toxicity following chronic administration of ciprofibrate to rat, mouse, and marmoset.
    Toxicology and applied pharmacology, 1988, Sep-15, Volume: 95, Issue:2

    Topics: Animals; Callitrichinae; Clofibrate; Clofibric Acid; Fibric Acids; Gastrins; Male; Mice; Rats; Rats, Inbred F344; Species Specificity; Stomach

1988
PPARalpha agonists stimulate progastrin production in human colorectal carcinoma cells.
    Regulatory peptides, 2004, Aug-15, Volume: 120, Issue:1-3

    Topics: Bezafibrate; Cell Proliferation; Clofibrate; Clofibric Acid; Colorectal Neoplasms; Fenofibrate; Fibric Acids; Gastrins; Gemfibrozil; Humans; Hypolipidemic Agents; Ligands; Peroxisome Proliferator-Activated Receptors; Protein Precursors; Pyrimidines; Radioimmunoassay; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Vasodilator Agents

2004